Clinical trials data
Verbal Learning in anxiety, PTSD and OCD trials: 70 registered studies
Every registered anxiety, PTSD and OCD study on ClinicalTrials.gov that names Verbal Learning in an outcome measure: how often it is a primary outcome, the tests named with it, how large the studies are and when they measure it.
- Registered anxiety, PTSD and OCD studies name it in an outcome measure
- 70
- Name it in a primary outcome, 39%
- 27 of 70
Tests named in the same studies
- 1
Digit Span Test23 studies, 8 as a primary outcome
- 2
Verbal Fluency22 studies, 11 as a primary outcome
- 3
Trail Making Test22 studies, 10 as a primary outcome
- 4
Stroop Color-Word Test17 studies, 5 as a primary outcome
- 5
Symbol Coding11 studies, 2 as a primary outcome
- 6
Continuous Performance Test9 studies, 6 as a primary outcome
- 7
Go/No-Go Task8 studies, 3 as a primary outcome
- 8
Card Sorting Test (Berg)6 studies, 2 as a primary outcome
- 9
Iowa Gambling Lite6 studies, 1 as a primary outcome
- 10
AX Continuous Performance Test6 studies, 0 as a primary outcome
A test as a primary outcomeOnly in secondary or other outcomes
Studies by start year
A test as a primary outcomeOnly in secondary or other outcomes
Show as a table
| Start year | Studies | A test as a primary outcome |
|---|---|---|
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 1 | 1 |
| 2004 | 1 | 1 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 1 | 0 |
| 2009 | 2 | 0 |
| 2010 | 3 | 1 |
| 2011 | 1 | 1 |
| 2012 | 2 | 1 |
| 2013 | 1 | 0 |
| 2014 | 2 | 0 |
| 2015 | 4 | 4 |
| 2016 | 5 | 1 |
| 2017 | 4 | 1 |
| 2018 | 2 | 1 |
| 2019 | 5 | 2 |
| 2020 | 3 | 1 |
| 2021 | 10 | 6 |
| 2022 | 2 | 0 |
| 2023 | 5 | 1 |
| 2024 | 6 | 2 |
| 2025 | 5 | 1 |
| 2026 | 4 | 2 |
Phases and study sizes
By phase
- Early phase 13 studies, 2 as a primary outcome
- Phase 14 studies, 2 as a primary outcome
- Phase 1/24 studies, 2 as a primary outcome
- Phase 28 studies, 1 as a primary outcome
- Phase 2/31 studies, 0 as a primary outcome
- Phase 32 studies, 0 as a primary outcome
- Phase 42 studies, 0 as a primary outcome
- Not applicable42 studies, 17 as a primary outcome
- Observational4 studies, 3 as a primary outcome
Participants per study
- Not applicable60 median, 41 to 98
Show as a table
| Phase | Studies with a size | Median | Middle half |
|---|---|---|---|
| Not applicable | 38 | 60 | 41 to 98 |
When anxiety, PTSD and OCD trials measure it
Latest time point of each outcome
- Within a day5 outcomes, 1 as a primary outcome
- Up to 4 weeks8 outcomes, 2 as a primary outcome
- 1 to 3 months29 outcomes, 11 as a primary outcome
- 3 to 6 months14 outcomes, 5 as a primary outcome
- 6 to 12 months6 outcomes, 1 as a primary outcome
- 1 to 2 years3 outcomes, 2 as a primary outcome
- No duration given5 outcomes, 5 as a primary outcome
A test as a primary outcomeOnly in secondary or other outcomes
65 of the 70 outcome measures give a duration. A single visit counts as within a day.
Status, results, interventions and countries
Status
- Recruiting11 studies, 4 as a primary outcome
- Not yet recruiting2 studies, 1 as a primary outcome
- Active, not recruiting4 studies, 1 as a primary outcome
- Completed34 studies, 15 as a primary outcome
- Stopped early11 studies, 4 as a primary outcome
- Status unknown8 studies, 2 as a primary outcome
What they test
- Behavioral25 studies, 11 as a primary outcome
- Drug18 studies, 5 as a primary outcome
- Device12 studies, 4 as a primary outcome
- Dietary supplement6 studies, 3 as a primary outcome
- Procedure1 studies, 1 as a primary outcome
- Radiation2 studies, 1 as a primary outcome
- Other13 studies, 6 as a primary outcome
- None given2 studies, 2 as a primary outcome
Intervention types as registered. A study can list several; observational studies often list none.
Where their sites are
- United States38 studies, 15 as a primary outcome
- Canada12 studies, 5 as a primary outcome
- Netherlands3 studies, 1 as a primary outcome
- United Kingdom2 studies, 0 as a primary outcome
- China1 studies, 0 as a primary outcome
- Denmark1 studies, 1 as a primary outcome
- Egypt1 studies, 0 as a primary outcome
- France1 studies, 0 as a primary outcome
- Germany1 studies, 1 as a primary outcome
- India1 studies, 1 as a primary outcome
- Norway1 studies, 0 as a primary outcome
- Poland1 studies, 0 as a primary outcome
14 countries in all. A study with sites in several counts in each; 5 list no site.
Reported results
Completed studies with results posted on ClinicalTrials.gov, a results paper the registry links to the study, or both.
Completed anxiety, PTSD and OCD studies that name Verbal Learning: 16 of 34, 47%
Every completed study with a cognitive outcome: 3,626 of 7,953, 46%
| Results | Completed anxiety, PTSD and OCD studies that name Verbal Learning | Every completed study |
|---|---|---|
| Results on ClinicalTrials.gov and a paper | 5, 15% | 776, 10% |
| Results on ClinicalTrials.gov only | 8, 24% | 1,139, 14% |
| A results paper only | 3, 9% | 1,711, 22% |
| Neither | 18, 53% | 4,327, 54% |
The 70 studies
70 studies match. 27 name Verbal Learning in a primary outcome. Median size 60 participants. Median time to the primary outcome: 13 weeks.
Loading 70 studies; the filters turn on when they arrive.
2026 is partly planned starts. Not shown: 1 planned to start after 2026.
Show as a table
| Start year | Studies | As a primary outcome |
|---|---|---|
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 1 | 1 |
| 2004 | 1 | 1 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 1 | 0 |
| 2009 | 2 | 0 |
| 2010 | 3 | 1 |
| 2011 | 1 | 1 |
| 2012 | 2 | 1 |
| 2013 | 1 | 0 |
| 2014 | 2 | 0 |
| 2015 | 4 | 4 |
| 2016 | 5 | 1 |
| 2017 | 4 | 1 |
| 2018 | 2 | 1 |
| 2019 | 5 | 2 |
| 2020 | 3 | 1 |
| 2021 | 10 | 6 |
| 2022 | 2 | 0 |
| 2023 | 5 | 1 |
| 2024 | 6 | 2 |
| 2025 | 5 | 1 |
| 2026 | 4 | 2 |
Library tests named most
Largest condition groups
Phases
Participants
Lead sponsor: industry 1, other 69. Interventional 66, observational 4.
As a primary outcomeSecondary or other outcomeVerbal Learning
The studies, newest registration first
Each number opens the study's record on ClinicalTrials.gov.
| Study | Start | Phase | Conditions | Participants | Lead sponsor | Status | Library tests named, with the latest time point |
|---|---|---|---|---|---|---|---|
| NCT07693686 | Start2027 | PhaseNot applicable | ConditionsAnxiety, PTSD and OCD | Participants176 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07550140 | Start2026 | PhaseNot applicable | ConditionsDepression and bipolar disorder, Sleep and sleep disorders, Anxiety, PTSD and OCD | Participants60 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07506070 | Start2026 | PhaseNot applicable | ConditionsSchizophrenia and psychosis, Depression and bipolar disorder, Autism, Anxiety, PTSD and OCD | Participants160 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07393672 | Start2026 | PhasePhase 2 | ConditionsAnxiety, PTSD and OCD, Pain and fatigue | Participants104 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07309302 | Start2025 | PhaseNot applicable | ConditionsDepression and bipolar disorder, Anxiety, PTSD and OCD | Participants64 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07055633 | Start2026 | PhaseNot applicable | ConditionsBrain injury and concussion, Anxiety, PTSD and OCD | Participants144 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06831916 | Start2025 | PhasePhase 2 | ConditionsAnxiety, PTSD and OCD, Pain and fatigue | Participants104 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT06796712 | Start2025 | PhaseNot applicable | ConditionsDepression and bipolar disorder, Anxiety, PTSD and OCD | Participants55 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT06700590 | Start2024 | PhaseNot applicable | ConditionsAnxiety, PTSD and OCD | Participants186 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06638996 | Start2024 | PhaseNot applicable | ConditionsAnxiety, PTSD and OCD, Pain and fatigue | Participants100 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT06381180 | Start2025 | PhasePhase 1/2 | ConditionsSubstance use and addiction, Anxiety, PTSD and OCD | Participants500 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06356805 | Start2023 | PhaseNot applicable | ConditionsAnxiety, PTSD and OCD, Pain and fatigue | Participants42 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT06354361 | Start2024 | PhaseNot applicable | ConditionsAnxiety, PTSD and OCD | Participants33 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT06335407 | Start2025 | PhasePhase 1 | ConditionsSubstance use and addiction, Anxiety, PTSD and OCD | Participants10 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06290063 | Start2024 | PhasePhase 2 | ConditionsDepression and bipolar disorder, Sleep and sleep disorders, Anxiety, PTSD and OCD, Pain and fatigue | Participants385 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06198023 | Start2024 | PhaseNot applicable | ConditionsAnxiety, PTSD and OCD | Participants60 | Lead sponsorOther | StatusActive, not recruiting | Library tests named
|
| NCT06135064 | Start2024 | PhasePhase 1/2 | ConditionsAnxiety, PTSD and OCD | Participants10 | Lead sponsorOther | StatusStopped early | Library tests named
|
| NCT06032377 | Start2023 | PhaseNot applicable | ConditionsDepression and bipolar disorder, Sleep and sleep disorders, Anxiety, PTSD and OCD | Participants275 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT05964062 | Start2023 | PhaseNot applicable | ConditionsAnxiety, PTSD and OCD | Participants30 | Lead sponsorOther | StatusStatus unknown | Library tests named
|
| NCT05964049 | Start2023 | PhaseNot applicable | ConditionsAnxiety, PTSD and OCD | Participants30 | Lead sponsorOther | StatusStatus unknown | Library tests named
|
| NCT05541887 | Start2023 | PhaseNot applicable | ConditionsAnxiety, PTSD and OCD | Participants25 | Lead sponsorOther | StatusStopped early | Library tests named
|
| NCT05386862 | Start2022 | PhaseNot applicable | ConditionsSubstance use and addiction, Anxiety, PTSD and OCD | ParticipantsNot given | Lead sponsorOther | StatusStopped early | Library tests named
|
| NCT05289258 | Start2021 | PhaseNot applicable | ConditionsDepression and bipolar disorder, Cancer, Anxiety, PTSD and OCD | Participants123 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT05257044 | Start2022 | PhasePhase 1 | ConditionsAnxiety, PTSD and OCD | Participants38 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT05090839 | Start2021 | PhaseNot applicable | ConditionsAnxiety, PTSD and OCD | Participants40 | Lead sponsorOther | StatusCompleted | Library tests named
|
Questions, answered from the data
How many anxiety, PTSD and OCD trials use Verbal Learning?
70 registered anxiety, PTSD and OCD studies on ClinicalTrials.gov name it in an outcome measure, 27 of them in a primary outcome: 10% of the condition's 692 studies with a cognitive outcome, against 11% of all of them. It is the 3rd most named test in anxiety, PTSD and OCD trials.
Which tests do anxiety, PTSD and OCD trials use with Verbal Learning?
The Digit Span Test (23 studies), Verbal Fluency (22 studies) and the Trail Making Test (22 studies).
When do anxiety, PTSD and OCD trials measure Verbal Learning?
Half of the primary outcomes that name Verbal Learning are measured within 13 weeks of the start, and the middle half from 8 weeks to 6 months. 22 primary outcomes give a duration.
How many completed anxiety, PTSD and OCD trials that use Verbal Learning have reported results?
16 of the 34 completed studies that name it, 47%, have reported results: 13 posted them on ClinicalTrials.gov, 8 have a results paper linked to the registry record, and 5 did both. The other 18 show neither. Of all completed studies with a cognitive outcome, 46% have reported results.
How the studies are counted
For each test family, the census runs ClinicalTrials.gov's own outcome search for the family's names and reads every study first posted by the day the family was counted. These studies were read on 10 November 2026. A study counts once on a page, however many tests it names. Counts for a test cover every version of the task under any of its names, so a page can count studies that used a commercial version.
The census adds two things to each record and changes nothing in it: which outcome list names the test (primary, then secondary, then other), and the condition groups, matched on the study's condition names and MeSH terms. A study can fall in several groups; one whose only condition is cognitive impairment or decline falls in “Cognitive impairment and decline”. Studies that name only instruments outside the library count in every total and share but are not listed.
A second read on 10 November 2026 added each study's overall status, whether results are posted, its intervention types, the countries of its sites and the time frame of the outcome that names each test. A time frame counts by the latest time point it names: “Baseline, 12 and 24 weeks” is 24 weeks, a single visit is within a day, and one that names no duration, such as “end of treatment”, is left out of the timings.
A third read on 10 November 2026 added the papers the registry links to each study: those its sponsor lists as reporting results, and those PubMed links to it through the study's NCT number. A study has a results paper when one of them came out in or after the month of its primary completion and PubMed does not class it as a protocol, review or comment. A paper that never gives the NCT number is not linked, so some studies counted as reporting neither did publish.
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine, which does not endorse these pages. Every study line is in the data release 2.1.0, and the explorer's own file is clinical-trials-studies.json.
The census counts Verbal Learning and Grocery Trip Game as one test family, so this page counts their studies together.
Run Verbal Learning in your trial
Choose tests with a record in registered trials, and run them in a browser at every site, on the same version each visit.